SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001493152-21-002810
Filing Date
2021-02-05
Accepted
2021-02-05 16:49:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13da.htm SC 13D/A 52443
  Complete submission text file 0001493152-21-002810.txt   53853
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Subject) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: SC 13D/A | Act: 34 | File No.: 005-36989 | Film No.: 21596739
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6 AUTUMN LANE SARATOGA SPRINGS NY 12866
Business Address
Titterton Lewis H jr (Filed by) CIK: 0001499254 (see all company filings)

Type: SC 13D/A